On Oct 19, 2021 Locus Biosciences closed a Debt Financing round and raised $25,000,000 from Hercules Capital, featuring lead investors Hercules Capital. About the company: […]
Seed Round – Latch Bio
On Oct 1, 2021 Latch Bio closed a Seed round and raised $5,000,000 from Asimov, Fifty Years, General Catalyst, Haystack, Lux Capital, featuring lead investors […]
Grant – Pegasus Biotech
On Sep 20, 2021 Pegasus Biotech closed a Grant round and raised CA$100,000 from investors, featuring lead investors . About the company: Pegasus Biotech is […]
Grant – Pegasus Biotech
On Sep 20, 2021 Pegasus Biotech closed a Grant round and raised CA$100,000 from investors, featuring lead investors . About the company: Pegasus Biotech is […]
Series B – TreeFrog Therapeutics
On Sep 13, 2021 TreeFrog Therapeutics closed a Series B round and raised €64,000,000 from Bpifrance, Bristol Myers Squibb, Leonard Green & Partners, XAnge, featuring […]
Series C – Solugen
On Sep 9, 2021 Solugen closed a Series C round and raised $350,000,000 from Baillie Gifford, BlackRock, Carbon Direct, Fifty Years, GIC, Refactor Capital, Temasek […]
Series B – Attralus
On Sep 8, 2021 Attralus closed a Series B round and raised $116,000,000 from Janus Henderson Investors, Logos Capital, Redmile Group, Samsara BioCapital, Sarissa Capital […]
Series B – Attralus
On Sep 8, 2021 Attralus closed a Series B round and raised $116,000,000 from Janus Henderson Investors, Logos Capital, Redmile Group, Samsara BioCapital, Sarissa Capital […]
Post-IPO Equity – Adaptimmune
On Sep 7, 2021 Adaptimmune closed a Post-IPO Equity round and raised $150,000,000 from Genentech, featuring lead investors Genentech. About the company: Adaptimmune is located […]
Post-IPO Equity – Adaptimmune
On Sep 7, 2021 Adaptimmune closed a Post-IPO Equity round and raised $150,000,000 from Genentech, featuring lead investors Genentech. About the company: Adaptimmune is located […]
